NEL0 Stock Overview
Operates as a healthcare IT company in the United States, Canada, and the United Kingdom. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 2/6 |
| Dividends | 0/6 |
NantHealth, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.26 |
| 52 Week High | US$5.17 |
| 52 Week Low | US$0.20 |
| Beta | 1.64 |
| 11 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -93.60% |
| 33 Year Change | -99.06% |
| 5 Year Change | -98.24% |
| Change since IPO | -99.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| NEL0 | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | 0% | 2.3% | 0.8% |
| 1Y | -93.6% | -31.3% | 9.1% |
Return vs Industry: NEL0 underperformed the German Healthcare Services industry which returned -10.2% over the past year.
Return vs Market: NEL0 underperformed the German Market which returned 5.9% over the past year.
Price Volatility
| NEL0 volatility | |
|---|---|
| NEL0 Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 5.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: NEL0's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine NEL0's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 373 | Rao Naseem | nanthealth.com |
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. It offers Eviti, a software-as-a-service (SaaS) based clinical decision support solution that centralizes clinical content and treatment cost data from Medicare reimbursements and treatment toxicity data; Eviti Connect, which utilizes the platform to offer pre-authorization automation that helps payers and providers navigate the complexities of cancer care; and Eviti Advisor product that allows physicians to access the Eviti platform’s comprehensive library of evidence-based treatment standards and protocols to inform treatment decisions. The company also provides NaviNet, a suite of SaaS-based solution enabling payers and providers to streamline communication and consolidate information; NaviNet Open, a payer-provider collaboration platform for communication between health plans and providers; NaviNet AllPayer that provides eligibility, benefit, and claim status information to provider offices for commercial and government plans, and centers for medicare and medicaid services for Medicare beneficiaries through the NaviNet portal; and OpenNMS is an open-source network monitoring solution for enterprise-grade networks.
NantHealth, Inc. Fundamentals Summary
| NEL0 fundamental statistics | |
|---|---|
| Market cap | €11.54m |
| Earnings (TTM) | -€63.09m |
| Revenue (TTM) | €62.54m |
0.2x
P/S Ratio-0.2x
P/E RatioIs NEL0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NEL0 income statement (TTM) | |
|---|---|
| Revenue | US$68.44m |
| Cost of Revenue | US$23.74m |
| Gross Profit | US$44.69m |
| Other Expenses | US$113.74m |
| Earnings | -US$69.04m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.51 |
| Gross Margin | 65.31% |
| Net Profit Margin | -100.89% |
| Debt/Equity Ratio | -111.3% |
How did NEL0 perform over the long term?
See historical performance and comparison